Orally-Administered Caspase Inhibitor PF-03491390 Is Retained in the Liver for Prolonged Periods With Low Systemic Exposure, Exerting a Hepatoprotective Effect Against α-Fas-Induced Liver Injury in a Mouse ModelYoshinobu Ueno, Hiroyuki Eda, Mitsuko L. Yamamoto et al.|Journal of Pharmacological Sciences|2007Cited by 23